The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.
Recent Posts
- JPMorgan Chase unveils new Sapphire Reserve card perks and $795 annual fee
- Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge
- Luxury credit card rivalry heats up as Amex, JPMorgan tease updates to their premier cards
- China May retail sales sharply beat estimates; industrial output misses expectations
- Why aren’t Chinese consumers spending enough
Recent Comments